Gil Melmed

Dr. Hudesman is Director of the Inflammatory Bowel Disease Center at NYU Langone Health. He is Professor of Medicine at the NYU School of Medicine.

Dr. Hudesman specializes in the diagnosis and treatment of inflammatory bowel disease (IBD) and in the provision of integrated, seamless, patient-centered care. His research is focused on the development of biomarkers and evaluation and optimization of new medical therapies for the treatment of both Crohn’s disease and ulcerative colitis.

Dr. Hudesman served on the Educational Affairs Committee of the American College of Gastroenterology, and the Professional Membership Committee of the Crohn’s Colitis Foundation, and is currently on the Quality Committee of the American Gastroenterological Association.

Gil Y. Melmed, MD, MS, is the Clinical Director of the Inflammatory Bowel Disease Program and Associate Director of the Karsh Division of Digestive and Liver Diseases at Cedars-Sinai Medical Center in Los Angeles, California. He earned his medical degree from Albert Einstein College of Medicine in the Bronx, New York, and master of science in clinical research from UCLA School of Medicine, Los Angeles. Dr Melmed completed his gastroenterology fellowship at the University of California, Los Angeles.
He has authored or coauthored more than 250 articles in peer-reviewed journals and several book chapters. Dr Melmed has served as Associate Editor of the American Journal of Gastroenterology, an ad hoc reviewer for several journals, and clinical research editor for Inflammatory Bowel Disease. His research interests include clinical outcomes and quality of care in IBD. He has given invited lectures and presentations nationally and internationally on several clinical topics in inflammatory bowel disease, including quality of care and clinical outcomes. He is a committee member of several professional organizations, including the American College of Gastroenterology and the Crohn’s and Colitis Foundation, where he serves as co-chair of the IBD Quality of Care committee. He has led or participated in the development of quality measures for IBD with the American Gastroenterology Association, the Crohn’s and Colitis Foundation, and the Canadian Crohn’s and Colitis organizations.

Dr. Clarke is Professor and Chief of Gastroenterology and Hepatology, at The College of Medicine at Penn State Health Milton S. Hershey Medical Center. He is also the Graham Jeffries Endowed Professor of Medicine
Fellowships:
-Gastroenterology, Hepatology and Nutrition; University of Pittsburgh
-Research Fellowship; Michigan State University
Post Graduate:
-Medicine and Gastroenterology- Imperial College, Royal College of Physicians, London, UK

Additional Qualifications
-Certificate for Leadership Training for Physicians in Academic Medical Centers-
Harvard School of Public Health.
-Certificate of Completion, Penn State Leadership Academy

Clinical and Research Interests:
-Inflammatory Bowel Disease and Celiac Disease.
-Graduate Medical Education.

Lisa Malter, MD, FACG, is a Professor of Medicine at the NYU School of Medicine, the Director of Education for the NYU IBD Center and Director of the Inflammatory Bowel Disease Clinic at the Bellevue Hospital Center in New York City. Board-certified in Gastroenterology, Dr. Malter’s patient practice is focused primarily on inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, and she has pioneered access to care for the underserved patient population at Bellevue. Dr. Malter’s academic interests include the study of inflammatory bowel disease, patient safety, and fellowship education. Dr. Malter teaches at the NYU Grossman School of Medicine and has published in Inflammatory Bowel Diseases,  The American Journal of Gastroenterology and CC360. She is a member of ACG, AGA, and the Crohn's and Colitis Foundation. She serves as the Editor of the ACG Universe, is a member of the ACG Training Committee, the ACG Education Task Force, and is a faculty advisor for the Crohn's &Colitis Foundation's Greater New York Fellows’ Education Committee. She created and created and directs IBD 101, a first year fellows course on IBD, in collaboration with NYU and the ACG.  Dr. Malter received her medical degree from Rosalind Franklin University/Chicago Medical School, completed her internal medicine internship and residency at The Mount Sinai Hospital in New York, and went on to complete a Gastroenterology fellowship at NYU Langone Medical Center.

Dr Nuru Noor is a Clinical Lecturer in Gastroenterology based at the University of Cambridge in the UK. He also works as a Postdoctoral Research Associate at the Medical Research Council Clinical Trials Unit - the largest academic clinical trials unit in Europe. He has a particular interest in novel clinical trial designs, having completed his PhD on this topic. He is keen to bring novel methodological approaches to the field of Gastroenterology, and in particular to IBD - which is his main area of clinical interest and expertise.

Dr. Hudesman is Director of the Inflammatory Bowel Disease Center at NYU Langone Health. He is Professor of Medicine at the NYU School of Medicine.

Dr. Hudesman specializes in the diagnosis and treatment of inflammatory bowel disease (IBD) and in the provision of integrated, seamless, patient-centered care. His research is focused on the development of biomarkers and evaluation and optimization of new medical therapies for the treatment of both Crohn’s disease and ulcerative colitis.

Dr. Hudesman served on the Educational Affairs Committee of the American College of Gastroenterology, and the Professional Membership Committee of the Crohn’s Colitis Foundation, and is currently on the Quality Committee of the American Gastroenterological Association.

Gil Y. Melmed, MD, MS, is the Clinical Director of the Inflammatory Bowel Disease Program and Associate Director of the Karsh Division of Digestive and Liver Diseases at Cedars-Sinai Medical Center in Los Angeles, California. He earned his medical degree from Albert Einstein College of Medicine in the Bronx, New York, and master of science in clinical research from UCLA School of Medicine, Los Angeles. Dr Melmed completed his gastroenterology fellowship at the University of California, Los Angeles.
He has authored or coauthored more than 250 articles in peer-reviewed journals and several book chapters. Dr Melmed has served as Associate Editor of the American Journal of Gastroenterology, an ad hoc reviewer for several journals, and clinical research editor for Inflammatory Bowel Disease. His research interests include clinical outcomes and quality of care in IBD. He has given invited lectures and presentations nationally and internationally on several clinical topics in inflammatory bowel disease, including quality of care and clinical outcomes. He is a committee member of several professional organizations, including the American College of Gastroenterology and the Crohn’s and Colitis Foundation, where he serves as co-chair of the IBD Quality of Care committee. He has led or participated in the development of quality measures for IBD with the American Gastroenterology Association, the Crohn’s and Colitis Foundation, and the Canadian Crohn’s and Colitis organizations.

Dr. Clarke is Professor and Chief of Gastroenterology and Hepatology, at The College of Medicine at Penn State Health Milton S. Hershey Medical Center. He is also the Graham Jeffries Endowed Professor of Medicine
Fellowships:
-Gastroenterology, Hepatology and Nutrition; University of Pittsburgh
-Research Fellowship; Michigan State University
Post Graduate:
-Medicine and Gastroenterology- Imperial College, Royal College of Physicians, London, UK

Additional Qualifications
-Certificate for Leadership Training for Physicians in Academic Medical Centers-
Harvard School of Public Health.
-Certificate of Completion, Penn State Leadership Academy

Clinical and Research Interests:
-Inflammatory Bowel Disease and Celiac Disease.
-Graduate Medical Education.

Lisa Malter, MD, FACG, is a Professor of Medicine at the NYU School of Medicine, the Director of Education for the NYU IBD Center and Director of the Inflammatory Bowel Disease Clinic at the Bellevue Hospital Center in New York City. Board-certified in Gastroenterology, Dr. Malter’s patient practice is focused primarily on inflammatory bowel disease, including Crohn’s disease and ulcerative colitis, and she has pioneered access to care for the underserved patient population at Bellevue. Dr. Malter’s academic interests include the study of inflammatory bowel disease, patient safety, and fellowship education. Dr. Malter teaches at the NYU Grossman School of Medicine and has published in Inflammatory Bowel Diseases,  The American Journal of Gastroenterology and CC360. She is a member of ACG, AGA, and the Crohn's and Colitis Foundation. She serves as the Editor of the ACG Universe, is a member of the ACG Training Committee, the ACG Education Task Force, and is a faculty advisor for the Crohn's &Colitis Foundation's Greater New York Fellows’ Education Committee. She created and created and directs IBD 101, a first year fellows course on IBD, in collaboration with NYU and the ACG.  Dr. Malter received her medical degree from Rosalind Franklin University/Chicago Medical School, completed her internal medicine internship and residency at The Mount Sinai Hospital in New York, and went on to complete a Gastroenterology fellowship at NYU Langone Medical Center.

Dr Nuru Noor is a Clinical Lecturer in Gastroenterology based at the University of Cambridge in the UK. He also works as a Postdoctoral Research Associate at the Medical Research Council Clinical Trials Unit - the largest academic clinical trials unit in Europe. He has a particular interest in novel clinical trial designs, having completed his PhD on this topic. He is keen to bring novel methodological approaches to the field of Gastroenterology, and in particular to IBD - which is his main area of clinical interest and expertise.

Neilanjan Nandi, MD, FACG, AGAF, FCCF, FACP is an Associate Professor of Clinical Medicine at the Perelman School of Medicine, University of Pennsylvania and is the Co-Section Head and Direcotr of Clinical Operations of the University of Pennsylvania Inflammatory Bowel Disease Program. Dr. Nandi specializes in the complex management of Crohn's disease, Ulcerative Colitis and recurrent C. difficile infection (C difficile). He has also authored numerous abstracts, publications and book chapters on the diagnosis and management of IBD, C difficile and various viral, parasitic, mycobacterial and bacterial infections of the GI tract. Aligning with his interests, Dr. Nandi has conducted several clinical trials focused on the clinical impact of stool derived microbiome therapies in C difficile and IBD. Dr. Nandi servies on the Philadelphia/Delaware Valley Crohn's & Colitis Foundation (CCF) Executive Council and on the Medical Advisory Board of the United Ostomy Associates of America (UOAA). He is a founding non-profit board member and Chair of the South Asian IBD Alliance (SAIA) which elevates culturally competent care in South Asian IBD. He has been recognized with the 2019 Philly Take STeps Physician Hero, the 2022 CCF's National Chairman’s Citation Award and the 2024 CCF's Gold Medallion Physician Award. He is the honored recipient of the 2023 Sidney Cohen GI Faculty Teaching Award and the 2024 Radhika Srinivasan GI Faculty award for Professionalism and Humanism at the Perelman School of Medicine.

Jessiy Salwen-Deremer, Ph.D., DBSM, is the Director of Behavioral Medicine for Digestive Health at Dartmouth-Hitchcock Medical Center and Assistant Professor of Psychiatry & Medicine at the Geisel School of Medicine at Dartmouth. Dr. Salwen-Deremer earned her Ph.D. in clinical psychology at Stony Brook University and completed her fellowship training in behavioral medicine at the Johns Hopkins School of Medicine. Her areas of clinical expertise include behavioral sleep medicine and gastropsychology. Her research expertise encompasses two areas: understanding the impact of sleep disorders on inflammatory bowel diseases and improving access to gastrointestinal behavioral health care. Across both of these areas, she focuses on the integration of telehealth and remote technologies to enhance patient engagement and participation.

Dr. Aline Charabaty is Professor of Medicine at the University of Maryland and the Director of the IBD Program at the University of Maryland Medical center. She is the Editor-in-Chief of the Crohn’s and Colitis 360 journal, and is past Vice-Chair of the AGA Research Foundation Executive Board, and past ACG Governor for Washington DC. Her work and advocacy were recognized by the Crohn’s and Colitis Foundation Excellence in Medicine Award in 2020 , the ACG Diversity Equity and Inclusion Award in 2025, and the AGA Beacon of Hope Award in 2026. Dr Charabaty uses social media to amplify medical education in IBD and is the founder of @MondayNightIBD a CME platform on twitter for which she received the Healio Disruptive Innovator Award in 2019. Dr Charabaty is a strong advocate for diversity and the professional advancement of women in GI. She is the Co-Founder of Scrubs & Heels, a foundation focused on empowering women in GI with the leadership skills, networking and mentorship to achieve professional goals and growth.

Kelly Issokson, MS, RD, CSDH, LDN, CNSC is the Senior Registered Dietitian of Outpatient Nutrition at the University of California, San Francisco (UCSF) and a nationally recognized expert in gastrointestinal nutrition. With over 17 years of clinical experience, she specializes in inflammatory bowel disease (IBD) and surgical nutrition. Ms. Issokson graduated magna cum laude from Johnson & Wales University and earned her MS in Nutrition from California State University, Northridge. She serves on the National Board of the Crohn’s & Colitis Foundation and is a leading voice in advancing nutrition as part of multidisciplinary IBD care. She co-developed the Cedars-Sinai IBD Prehabilitation Program and nutrition education training programs for physicians, APPs, and RDs.

Gil Y. Melmed, MD, MS, is the Clinical Director of the Inflammatory Bowel Disease Program and Associate Director of the Karsh Division of Digestive and Liver Diseases at Cedars-Sinai Medical Center in Los Angeles, California. He earned his medical degree from Albert Einstein College of Medicine in the Bronx, New York, and master of science in clinical research from UCLA School of Medicine, Los Angeles. Dr Melmed completed his gastroenterology fellowship at the University of California, Los Angeles.
He has authored or coauthored more than 250 articles in peer-reviewed journals and several book chapters. Dr Melmed has served as Associate Editor of the American Journal of Gastroenterology, an ad hoc reviewer for several journals, and clinical research editor for Inflammatory Bowel Disease. His research interests include clinical outcomes and quality of care in IBD. He has given invited lectures and presentations nationally and internationally on several clinical topics in inflammatory bowel disease, including quality of care and clinical outcomes. He is a committee member of several professional organizations, including the American College of Gastroenterology and the Crohn’s and Colitis Foundation, where he serves as co-chair of the IBD Quality of Care committee. He has led or participated in the development of quality measures for IBD with the American Gastroenterology Association, the Crohn’s and Colitis Foundation, and the Canadian Crohn’s and Colitis organizations.

Neilanjan Nandi, MD, FACG, AGAF, FCCF, FACP is an Associate Professor of Clinical Medicine at the Perelman School of Medicine, University of Pennsylvania and is the Co-Section Head and Direcotr of Clinical Operations of the University of Pennsylvania Inflammatory Bowel Disease Program. Dr. Nandi specializes in the complex management of Crohn's disease, Ulcerative Colitis and recurrent C. difficile infection (C difficile). He has also authored numerous abstracts, publications and book chapters on the diagnosis and management of IBD, C difficile and various viral, parasitic, mycobacterial and bacterial infections of the GI tract. Aligning with his interests, Dr. Nandi has conducted several clinical trials focused on the clinical impact of stool derived microbiome therapies in C difficile and IBD. Dr. Nandi servies on the Philadelphia/Delaware Valley Crohn's & Colitis Foundation (CCF) Executive Council and on the Medical Advisory Board of the United Ostomy Associates of America (UOAA). He is a founding non-profit board member and Chair of the South Asian IBD Alliance (SAIA) which elevates culturally competent care in South Asian IBD. He has been recognized with the 2019 Philly Take STeps Physician Hero, the 2022 CCF's National Chairman’s Citation Award and the 2024 CCF's Gold Medallion Physician Award. He is the honored recipient of the 2023 Sidney Cohen GI Faculty Teaching Award and the 2024 Radhika Srinivasan GI Faculty award for Professionalism and Humanism at the Perelman School of Medicine.

Jessiy Salwen-Deremer, Ph.D., DBSM, is the Director of Behavioral Medicine for Digestive Health at Dartmouth-Hitchcock Medical Center and Assistant Professor of Psychiatry & Medicine at the Geisel School of Medicine at Dartmouth. Dr. Salwen-Deremer earned her Ph.D. in clinical psychology at Stony Brook University and completed her fellowship training in behavioral medicine at the Johns Hopkins School of Medicine. Her areas of clinical expertise include behavioral sleep medicine and gastropsychology. Her research expertise encompasses two areas: understanding the impact of sleep disorders on inflammatory bowel diseases and improving access to gastrointestinal behavioral health care. Across both of these areas, she focuses on the integration of telehealth and remote technologies to enhance patient engagement and participation.

Dr. Aline Charabaty is Professor of Medicine at the University of Maryland and the Director of the IBD Program at the University of Maryland Medical center. She is the Editor-in-Chief of the Crohn’s and Colitis 360 journal, and is past Vice-Chair of the AGA Research Foundation Executive Board, and past ACG Governor for Washington DC. Her work and advocacy were recognized by the Crohn’s and Colitis Foundation Excellence in Medicine Award in 2020 , the ACG Diversity Equity and Inclusion Award in 2025, and the AGA Beacon of Hope Award in 2026. Dr Charabaty uses social media to amplify medical education in IBD and is the founder of @MondayNightIBD a CME platform on twitter for which she received the Healio Disruptive Innovator Award in 2019. Dr Charabaty is a strong advocate for diversity and the professional advancement of women in GI. She is the Co-Founder of Scrubs & Heels, a foundation focused on empowering women in GI with the leadership skills, networking and mentorship to achieve professional goals and growth.

Kelly Issokson, MS, RD, CSDH, LDN, CNSC is the Senior Registered Dietitian of Outpatient Nutrition at the University of California, San Francisco (UCSF) and a nationally recognized expert in gastrointestinal nutrition. With over 17 years of clinical experience, she specializes in inflammatory bowel disease (IBD) and surgical nutrition. Ms. Issokson graduated magna cum laude from Johnson & Wales University and earned her MS in Nutrition from California State University, Northridge. She serves on the National Board of the Crohn’s & Colitis Foundation and is a leading voice in advancing nutrition as part of multidisciplinary IBD care. She co-developed the Cedars-Sinai IBD Prehabilitation Program and nutrition education training programs for physicians, APPs, and RDs.

Gil Y. Melmed, MD, MS, is the Clinical Director of the Inflammatory Bowel Disease Program and Associate Director of the Karsh Division of Digestive and Liver Diseases at Cedars-Sinai Medical Center in Los Angeles, California. He earned his medical degree from Albert Einstein College of Medicine in the Bronx, New York, and master of science in clinical research from UCLA School of Medicine, Los Angeles. Dr Melmed completed his gastroenterology fellowship at the University of California, Los Angeles.
He has authored or coauthored more than 250 articles in peer-reviewed journals and several book chapters. Dr Melmed has served as Associate Editor of the American Journal of Gastroenterology, an ad hoc reviewer for several journals, and clinical research editor for Inflammatory Bowel Disease. His research interests include clinical outcomes and quality of care in IBD. He has given invited lectures and presentations nationally and internationally on several clinical topics in inflammatory bowel disease, including quality of care and clinical outcomes. He is a committee member of several professional organizations, including the American College of Gastroenterology and the Crohn’s and Colitis Foundation, where he serves as co-chair of the IBD Quality of Care committee. He has led or participated in the development of quality measures for IBD with the American Gastroenterology Association, the Crohn’s and Colitis Foundation, and the Canadian Crohn’s and Colitis organizations.